Evidence map›Paper›PMID 23627825›Full record

ReviewRegenerative medicine2013

The potential of stem cells for the restoration of auditory function in humans.

Zhengqing Hu, Mats Ulfendahl

Abstract readReview
In one paragraph

Review in Regenerative medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Differentiation capacity of dental pulp stem cell into inner ear hair cell using an in vitro assay: a preliminary step toward treating sensorineural hearing loss.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Gene therapy for hearing loss.Human molecular genetics · 2019
    Review
  11. Article
  12. Review
  13. Review
  14. Genetics of Hearing Loss: Syndromic.Otolaryngologic clinics of North America · 2015
    Review
  15. New treatment options for hearing loss.Nature reviews. Drug discovery · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Stem-cell therapy for hearing loss: are we there yet?Brazilian journal of otorhinolaryngology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhengqing HuDepartment of Otolaryngology-HNS, Wayne State University, MI, USA. zh@med.wayne.edu
Mats Ulfendahl

Funding

Reconstruction of the ascending neural circuit from the spiral ganglion R03DC011597 · NIDCD · WAYNE STATE UNIVERSITY · PI HU, ZHENGQING · 2011 to 2013
$448k
NIDCD NIH HHS R03 DC011597NIDCD NIH HHS R03DC011597
6 · The paper itself

Abstract

Hearing loss is one of the most common disabilities, affecting approximately 10% of the population. Hair cells and spiral ganglion neurons are usually damaged in most cases of hearing loss. Currently, there is virtually no biological approach to replace damaged hearing cells. Recent developments in stem cell technology provide new opportunities for the treatment of deafness. Two major strategies have been investigated: differentiation of endogenous stem cells into new hair cells; and introduction of exogenous cells into the inner ear to substitute injured hearing neurons. Although there is still a learning curve in stem cell-based replacement, the probability exists to utilize personalized stem cells to eventually provide a novel intervention for patients with deafness in future clinical research trials.

Indexed as

Stem Cell TransplantationAnimalsHearing LossHumansRegenerationStem Cells

Identifiers

PMID23627825
PMCPMC3802542

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.